Cargando…

Increasing injection frequency enhances the survival of injected bone marrow derived mesenchymal stem cells in a critical limb ischemia animal model

Critical limb ischemia (CLI) is one of the most severe forms of peripheral artery diseases, but current treatment strategies do not guarantee complete recovery of vascular blood flow or reduce the risk of mortality. Recently, human bone marrow derived mesenchymal stem cells (MSCs) have been reported...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Woong Chol, Oh, Pyung Chun, Lee, Kyounghoon, Ahn, Taehoon, Byun, Kyunghee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Physiological Society and The Korean Society of Pharmacology 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106400/ https://www.ncbi.nlm.nih.gov/pubmed/27847443 http://dx.doi.org/10.4196/kjpp.2016.20.6.657

Ejemplares similares

Bone marrow stem cell injection for the treatment of critical limb ischemia
por: Shindo, S
Publicado: (2007)

Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP
por: Yu, Jongwook, et al.
Publicado: (2017)

The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty
por: Oh, Pyung Chun, et al.
Publicado: (2016)

Diagnostic and prognostic role of nitroglycerin-induced dilation in patients with suspected vasospastic angina, combined with ergonovine provocation test
por: Kim, Minsu, et al.
Publicado: (2021)

A misplaced intramuscular injection and limb-threatening ischemia
por: Sarkar, Sumantra, et al.
Publicado: (2017)

Real-World Treatment Selection Factors and 7-Year Clinical Outcomes between Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Left Main Disease
por: Jang, Albert Youngwoo, et al.
Publicado: (2022)

Clinical Outcomes according to the Achievement of Target Low Density Lipoprotein-Cholesterol in Patients with Acute Myocardial Infarction
por: Ahn, Taehoon, et al.
Publicado: (2017)

Acute Severe Symptomatic Hyponatremia Following Coronary Angiography
por: Jung, Eul Sik, et al.
Publicado: (2011)

Advanced glycation end-product (AGE)-albumin from activated macrophage is critical in human mesenchymal stem cells survival and post-ischemic reperfusion injury
por: Son, Myeongjoo, et al.
Publicado: (2017)

Bone Marrow Cell Injection for Chronic Myocardial Ischemia: The Past and the Future
por: van Ramshorst, Jan, et al.
Publicado: (2011)

Characterization of Mesenchymal Stem Cells of “No-Options” Patients with Critical Limb Ischemia Treated by Autologous Bone Marrow Mononuclear Cells
por: Altaner, Cestmir, et al.
Publicado: (2013)

Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy
por: Nammian, Pegah, et al.
Publicado: (2021)

Critical Limb Ischemia
por: Schanzer, Andres, et al.
Publicado: (2010)

Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia
por: Liew, Aaron, et al.
Publicado: (2012)

Mesenchymal stromal cells for the treatment of critical limb ischemia: context and perspective
por: Gremmels, Hendrik, et al.
Publicado: (2013)

Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia
por: Madaric, Juraj, et al.
Publicado: (2016)

The Thromboembolic Predictability of CHA(2)DS(2)-VASc Scores Using Different Echocardiographic Criteria for Congestive Heart Failure in Korean Patients with Nonvalvular Atrial Fibrillation
por: Jang, Albert Youngwoo, et al.
Publicado: (2022)

Establishment of NOAEL for intracavernous injections of human bone marrow-derived mesenchymal stem cells in rats
por: Kim, Jong Keun, et al.
Publicado: (2020)

Real-World Long-Term Clinical Outcomes of Ultrathin Strut Biodegradable Polymer Drug-Eluting Stents in Korean ST-Segment-Elevation Myocardial Infarction (STEMI) Patients with or without Acute Heart Failure Undergoing Primary Percutaneous Coronary Intervention
por: Jang, Albert Youngwoo, et al.
Publicado: (2021)

Deciphering the in vivo Dynamic Proteomics of Mesenchymal Stem Cells in Critical Limb Ischemia
por: Du, Yipeng, et al.
Publicado: (2021)

Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia
por: Shirbaghaee, Zeinab, et al.
Publicado: (2022)

Mesenchymal stem cells for critical limb ischemia: their function, mechanism, and therapeutic potential
por: Lozano Navarro, Laura V., et al.
Publicado: (2022)

Bone Marrow Alterations and Lower Endothelial Progenitor Cell Numbers in Critical Limb Ischemia Patients
por: Teraa, Martin, et al.
Publicado: (2013)

Angiographic Change After Injection of Beperminogene Perplasmid, a Hepatocyte Growth Factor Gene Therapy Product for the Treatment of Critical Limb Ischemia
por: Kakei, Yusuke, et al.
Publicado: (2021)

Addition of routine blood biomarkers to TIMI risk score improves predictive performance of 1-year mortality in patients with ST-segment elevation myocardial infarction
por: Oh, Pyung Chun, et al.
Publicado: (2020)

Successful limb salvage by endovascular treatment for critical limb ischemia subsequent to acute limb ischemia
por: Nomura, Tetsuya, et al.
Publicado: (2019)

The Association of Cannabis Use Disorder with Acute Limb Ischemia and Critical Limb Ischemia
por: McGuinness, Brandon, et al.
Publicado: (2022)

Acute Limb Ischemia Caused by Inadvertent Arterial Drug Self-Injection: A Case Report
por: Maldarelli, Mary Elizabeth, et al.
Publicado: (2021)

Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia
por: Beegle, Julie R, et al.
Publicado: (2016)

The Diagnostic Classification of Critical Limb Ischemia
por: Azuma, Nobuyoshi
Publicado: (2018)

Prognostic impact of the combination of serum transaminase and alkaline phosphatase determined in the emergency room in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Oh, Pyung Chun, et al.
Publicado: (2020)

Acute limb ischemia due to diclofenac sodium iatrogenic intra-arterial injection: a case report
por: Banana, Youssef, et al.
Publicado: (2023)

Graz Critical Limb Ischemia Score: A Risk Score for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease
por: Gary, Thomas, et al.
Publicado: (2015)

Obstruction of Small Arterioles in Patients with Critical Limb Ischemia due to Partial Endothelial-to-Mesenchymal Transition
por: Chevalier, Jacqueline, et al.
Publicado: (2020)

In vivo tracking of intravenously injected mesenchymal stem cells in an Alzheimer’s animal model
por: Park, Bok-Nam, et al.
Publicado: (2018)

Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia
por: Skóra, Jan, et al.
Publicado: (2014)

Systematic investigation of transcription factors critical in the protection against cerebral ischemia by Danhong injection
por: Wei, Junying, et al.
Publicado: (2016)

Frequency and momentum tolerances at injection
por: Johnsen, Kjell
Publicado: (1953)

Intraarticular injection of bone marrow-derived mesenchymal stem cells enhances regeneration in knee osteoarthritis
por: Doyle, Emily Claire, et al.
Publicado: (2020)

Our Treatment Strategy for Critical Limb Ischemia
por: Yamada, Tetsuo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a1m8o72itjilhlpejh8b8nbs6l